2023欧洲心脏病学会心力衰竭协会《临床共识声明:慢性心力衰竭恶化的定义、流行病学、管理和预防》解读

Interpretation to the 2023 clinical consensus statement for definition,epidemiology,management and prevention by the Heart Failure Association of the European Society of Cardiology

慢性心力衰竭(chronic heart failure,CHF)恶化不仅会降低患者生活质量,增加住院及死亡风险,且给医疗卫生资源增加沉重负担。为更好地管理CHF,2023年欧洲心脏病学会心力衰竭协会制定新的临床共识声明,对CHF恶化的定义、临床特征、管理及预防等观点进行更新。该共识强调利尿剂的重要性,临床需根据患者CHF严重程度选择静脉、口服或联合使用利尿剂;早期、快速给予指南推荐的药物治疗可预防CHF的首次恶化及反复发作。为缓解医疗压力,满足患者及时就诊的需求,建议对患者进行分级诊疗,轻中度患者在急诊或门诊治疗,重度患者需住院治疗。该文就相关内容作简要解读,以期为临床CHF的临床管理提供参考。

The deterioration of chronic heart failure(CHF)not only reduces the quality of life of patients,increases the risk of hospitalization and death,but also imposes a heavy burden on healthcare resources.In order to better manage CHF,the Heart Failure Association of the European Society of Cardiology has developed a new clinical consensus statement in 2023,updating the definition,clinical characteristics,management,and prevention of CHF deterioration.The consensus highlights the importance of diuretics,and intravenous,oral or combined diuretics should be selected depending on the severity of the patient.It also emphasizes the importance of early and rapid administration of guideline recommended medical therapies to prevent first deterioration and repeated exacerbations of heart failure.In order to relieve the medical pressure and meet the needs of patients for timely treatment,it is recommended to carry out hierarchical diagnosis and treatment for patients,mild to moderate patients in emergency or outpatient treatment,severe patients need to choose hospital treatment.This article provided a brief interpretation of the relevant content in order to provide reference for the clinical management of CHF.